,i #aahth ,,congress #ast ,session ,h4 ,r4 #fgdi ,,in ,,the ,,house ,,of ,,representatives ,december #ac1 #bjbc,ms4 ,clarke of ,new ,york 7for herself1 ,mrs4 ,lesko1 ,ms4 ,blunt ,rochester1 ,ms4 ,houlahan1 ,mr4 ,ryan1 ,ms4 ,wild1 ,ms4 ,lee of ,california1 ,mrs4 ,cammack1 ,ms4 ,velzquez1 ,mr4 ,posey1 ,ms4 ,sewell1 ,mr4 ,grijalva1 ,ms4 ,tlaib1 ,ms4 ,williams of ,georgia1 ,mrs4 ,ramirez1 ,mr4 ,tonko1 ,ms4 ,norton1 ,mr4 ,nadler1 ,ms4 ,moore of ,wisconsin1 ,mr4 ,davis of ,north ,carolina1 ,ms4 ,porter1 ,mr4 ,green of ,texas1 ,ms4 ,crockett1 ,mr4 ,allred1 ,mrs4 ,cherfilus-,mc,cormick1 ,ms4 ,kelly of ,illinois1 ,mr4 ,jackson of ,illinois1 ,mr4 ,lawler1 ,mrs4 ,watson ,coleman1 ,ms4 ,barragn1 ,ms4 ,caraveo1 ,mr4 ,garca of ,illinois1 ,mr4 ,trone1 ,mr4 ,vargas1 ,mrs4 ,beatty1 ,mrs4 ,fletcher1 ,mr4 ,fitzpatrick1 ,ms4 ,kuster1 ,ms4 ,adams1 ,ms4 ,pingree1 and ,mr4 ,takano7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to require the ,director of the ,national ,institutes of ,health to evaluate the results and status of completed and ongoing research related to menopause1 perimenopause1 or mid-life women's health1 to conduct and support additional such research1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,menopause ,research and ,equity ,act of #bjbc4 #b4 ,evaluation of completed and ongoing research related to menopause1 perimenopause1 or mid-life women's health 7a7 ,in general ,the ,director of the ,national ,institutes of ,health shall-- 7#a7 conduct an evaluation of-- 7,a7 the results of research related to menopause1 perimenopause1 or mid-life women's health that is complete2 7,b7 the status of such research that is ongoing2 and 7,c7 any gaps in knowledge and research on-- 7i7 treatments for menopause-related symptoms2 and 7ii7 the safety and effectiveness of treatments for menopause-related symptoms2 and 7#b7 as part of such evaluation1 identify the total amount of funding allocated by the ,national ,institutes of ,health for the conduct or support of research related to menopause1 perimenopause1 or mid-life women's health over the preceding #e fiscal years4 7b7 ,report2 strategic plan ,not later than #ahj days after the date of enactment of this ,act1 the ,director of the ,national ,institutes of ,health shall submit to the ,congress-- 7#a7 a plan to perform the evaluation under subsection 7a72 and 7#b7 a plan to develop a strategy1 based on such evaluation1 that will-- 7,a7 be designed and implemented by the ,director in cooperation with a multidisciplinary group of health professionals including gynecologists1 oncologists1 endocrinologists1 cardiologists1 and neuroscientists2 7,b7 include strategies to resolve the gaps in knowledge and research identified in the report2 and 7,c7 identify topics in need of further research relating to potential treatments for menopause-related symptoms4 #c4 ,additional research related to menopause1 perimenopause1 or mid-life women's health 7a7 ,additional research 7#a7 ,in general ,the ,secretary of ,health and ,human ,services1 acting through the ,director of the ,national ,institutes of ,health1 shall conduct or support research related to menopause1 perimenopause1 or mid-life women's health4 7#b7 ,required elements ,the research required by paragraph 7#a7 shall include-- 7,a7 research concerning causes1 symptoms1 and treatments for menopause1 perimenopause1 and other related mid-life women's health issues2 and 7,b7 a multidisciplinary study of the effects of hormonal treatment for menopausal symptoms4 #d4 ,no additional funds authorized to be appropriated ,no additional funds are authorized to be appropriated to carry out this section1 and this section shall be carried out using amounts otherwise available for such purpose4